Updated federal cervical cancer screening guidelines now include an option for women to self-collect samples at home for high-risk human papillomavirus (hrHPV) testing. According to experts […]

While the incidence of lung cancer is decreasing in men, it continues to rise in women. With more than 19,000 new cases in France each year, […]

Data from the LITESPARK-022 study supported adding belzutifan (Welireg) to standard adjuvant pembrolizumab for patients with clear cell renal cell carcinoma (RCC) that has a high […]

A meta-analysis involving more than 6000 men suggested that adding hormone therapy (HT) to radiation after radical prostatectomy improves overall survival (OS) in those with higher […]

The combination of belzutifan (Welireg) and lenvatinib (Lenvima) led to superior outcomes, compared with cabozantinib (Cabometyx), in a phase 3 trial of patients with advanced clear […]

Neoadjuvant and adjuvant enfortumab vedotin plus pembrolizumab (EVP) substantially improves event-free survival (EFS), overall survival (OS), and pathologic complete response rates vs neoadjuvant gemcitabine/cisplatin in patients […]

A trio of new studies, published simultaneously last month in Nature Medicine, add to growing evidence that manipulating the gut microbiome may enhance responses to immunotherapy […]